IRIS
MONDELLI, MARIO UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.327
AS - Asia 8.188
EU - Europa 6.603
SA - Sud America 1.241
Continente sconosciuto - Info sul continente non disponibili 546
AF - Africa 236
OC - Oceania 18
AN - Antartide 1
Totale 28.160
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.062
CN - Cina 3.979
SG - Singapore 1.806
IE - Irlanda 1.389
BR - Brasile 928
UA - Ucraina 888
HK - Hong Kong 879
DE - Germania 802
FI - Finlandia 731
VN - Vietnam 708
IT - Italia 702
RU - Federazione Russa 642
FR - Francia 456
SE - Svezia 381
GB - Regno Unito 330
IN - India 156
BD - Bangladesh 152
CA - Canada 148
AR - Argentina 107
ZA - Sudafrica 85
IQ - Iraq 69
JP - Giappone 64
MX - Messico 63
EC - Ecuador 55
ID - Indonesia 50
CO - Colombia 44
PL - Polonia 43
TR - Turchia 38
NL - Olanda 37
PK - Pakistan 35
VE - Venezuela 34
ES - Italia 33
AT - Austria 32
MA - Marocco 28
SA - Arabia Saudita 28
UZ - Uzbekistan 26
CZ - Repubblica Ceca 25
CL - Cile 20
TN - Tunisia 20
DZ - Algeria 19
BE - Belgio 18
KE - Kenya 18
EG - Egitto 17
PH - Filippine 17
PY - Paraguay 17
IR - Iran 15
KZ - Kazakistan 14
MY - Malesia 14
AU - Australia 13
JO - Giordania 13
AZ - Azerbaigian 12
CH - Svizzera 12
NP - Nepal 12
PE - Perù 12
UY - Uruguay 12
IL - Israele 11
KG - Kirghizistan 11
LT - Lituania 10
TH - Thailandia 10
BH - Bahrain 9
OM - Oman 9
CR - Costa Rica 8
BO - Bolivia 7
GA - Gabon 7
GR - Grecia 7
NI - Nicaragua 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
BG - Bulgaria 6
EE - Estonia 6
EU - Europa 6
JM - Giamaica 6
LB - Libano 6
SN - Senegal 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
GT - Guatemala 5
HR - Croazia 5
KR - Corea 5
PS - Palestinian Territory 5
CI - Costa d'Avorio 4
HN - Honduras 4
HU - Ungheria 4
KW - Kuwait 4
LV - Lettonia 4
MU - Mauritius 4
PR - Porto Rico 4
QA - Qatar 4
RO - Romania 4
SI - Slovenia 4
SV - El Salvador 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
CY - Cipro 3
DK - Danimarca 3
GP - Guadalupe 3
GY - Guiana 3
Totale 27.555
Salva come PNG Salva come JPEG
Città #
Chandler 1.439
Dublin 1.385
Jacksonville 1.192
Ashburn 1.176
San Jose 1.136
Singapore 914
Nanjing 904
Hong Kong 869
Dallas 723
Beijing 526
Boardman 488
Council Bluffs 412
Nanchang 380
Princeton 323
Lawrence 289
Lauterbourg 284
Wilmington 272
Shenyang 254
Hebei 237
Changsha 231
Ho Chi Minh City 221
Jiaxing 220
Los Angeles 207
Helsinki 186
Milan 178
Tianjin 174
Medford 160
Hanoi 158
Munich 156
Hangzhou 139
New York 137
Buffalo 125
Redondo Beach 122
Moscow 120
Ann Arbor 99
Shanghai 94
Santa Clara 86
São Paulo 82
Pavia 79
Toronto 75
Verona 69
Orem 67
Tokyo 61
Turku 60
Woodbridge 60
Johannesburg 59
Norwalk 57
Seattle 51
Da Nang 42
Chicago 41
Brooklyn 38
The Dalles 37
Warsaw 36
Frankfurt am Main 35
Columbus 33
Zhengzhou 33
Baghdad 31
Chennai 31
Nuremberg 31
Denver 30
Guangzhou 30
Jinan 30
Des Moines 29
Haiphong 29
Montreal 29
Quito 27
Rio de Janeiro 27
Fairfield 26
London 25
Phoenix 24
Boston 23
Falkenstein 23
Houston 23
San Francisco 23
Tashkent 23
Dong Ket 22
Brasília 20
Falls Church 20
Manchester 20
Pune 20
Auburn Hills 19
Kunming 19
Curitiba 18
Stockholm 18
Amsterdam 17
Belo Horizonte 17
Brussels 17
Dhaka 17
Lahore 17
Nairobi 17
Rome 17
Washington 17
Atlanta 16
Mexico City 16
Charlotte 15
Guayaquil 15
Ningbo 15
Biên Hòa 14
Piscataway 14
Trieste 14
Totale 17.976
Salva come PNG Salva come JPEG
Nome #
MICA/B-targeted antibody promotes NK cell-driven tumor immunity in patients with intrahepatic cholangiocarcinoma 317
Mapping the human genetic architecture of COVID-19 306
A first update on mapping the human genetic architecture of COVID-19 209
Mapping the human genetic architecture of COVID-19 201
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 150
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 149
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 142
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 138
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 136
Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs 135
Cross-reactive antibodies to hypervariable region 1 (HVR1) of the hepatitis C virus E2/gp70 glycoprotein 129
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 129
Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 126
Development, Expansion, and Histological Characterization of Patient-Derived Liver Organoids for Drug Screening and Disease Modeling 121
Alfa-interferon enhances non-T cell cytotoxicity fo rautologous hepatocytes in acute and chronic HBV infection 121
Antibody responses to the hepatitis C virus (HCV) E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects. 121
A longitudinal analysis of hepatitis C virus replication following liver transplantation 121
CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. 120
COVID vaccination and asthma exacerbation: might there be a link? 120
Immunophatogenesis of viral hepatitis 118
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 118
Codon 72 polymorphisms of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients 117
Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. 117
A survey of hepatitis C virus infection in haemodialysis patients over a 7-years follow-up. 117
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 117
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 115
Acute hepatitis C: diagnosis and management. 115
A major conformational B cell epitope on the HCV NS3 region defined by a human monoclonal antibody 115
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 114
Detection of HTLV-III specific IgG in the CSF from patient with AIDS and encephalitis. 113
A human monoclonal antibody specific for a conserved epitope within the HCV protein 112
Hepatitis B virus structure and biology. 112
Recombinant human antibodies specific for hepatitis C virus proteins 112
Accuracy of the ElastPQ Technique for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C: a "Real Life" Single Center Study 112
Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma 112
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 112
GB virus C infection in patients treated for childhood acute lymphoblastic leukemia 111
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing? 111
Does the immune response play a role in the pathogenesis of chronic liver disease? 110
Antibody-negative chronic hepatitis C virus infection in immunocompetent children 109
A phase II, single arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection 109
Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in haemodialysis patients. 109
Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation 108
NKG2D and its ligands: key to immunotherapy of liver cancer? 108
Adenoviral mediated expression of anti-HCV NS3 single-chain Fv (sFv) antibody reduces HCV RNA in infected hepatocytes 108
Altered natural killer cell cytokine profile in type 2 autoimmune hepatitis 107
An anti-mica/b antibody and il-15 rescue altered nkg2d-dependent nk cell responses in hepatocellular carcinoma 107
High Frequencies of Functional Virus-Specific CD4+ T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders 107
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 106
A human monoclonal antibody specific for the N-terminus of hepatitis C virus nucleocapsid protein 106
Low prevalence of antibodies to the HCV envelope region in anti-HCV seronegative, HCV RNA positive patients 106
Absence of antibodies to human immunodeficiency virus in long-term institutionalized psychiatric patients. 106
Comparative evaluation of two serologic typing methods of hepatitis C virus 105
Analysis of hepatitis C virus hypervariable region 1 sequence in cryoglobulinaemic patients and associated control 105
Characterization of monoclonal antibodies (mAb) from mice immunized with HCV hypervariable region 1 (HVR1) mimotopes. 103
HCV genotype 1b is a major risk factor for the development of hepatocellular carcinoma (HCC) in cirrhotic patients: a prospective study 103
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. 102
Clinical significance of hepatitis C virus genotypes. 102
Clonality and specificity of cryoglobulins associated with HCV: pathophysiological implications 102
Association between class II allelles and protection or susceptibility to chronic hepatitis C 102
ANTIBODY RESPONSES TO HEPATITIS C VIRUS HYPERVARIABLE REGION 1: EVIDENCE FOR CROSS-REACTIVITY AND IMMUNE-MEDIATED SEQUENCE VARIATION. 102
Comparative evaluation of two serological typing methods for hepatitis C virus 102
Polymorphisms of microsomal epoxyde hydrolase gene and severity of HCV-related liver disease. 101
PD-L1 negatively regulates CD4+CD25+Foxp3+ tregs by limiting STAT-5 phosphrylation in patients chronically infected with HCV 101
Modelling liver fibrosis progression in chronic hepatitis C: a study of 563 patients with sequential liver biopsies 100
Molecular epidemiology of hepatitis C virus infection in intravenous drug users. 100
Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C 100
A human antibody specific for the hepatitis C virus core protein: expression in a bacterial system and characterization. 100
Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes 100
Monocytes inhibit hepatitis C virus-induced TRAIL expression on CD56brightNK cells 100
Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK Cells 99
Impaired intratumoral natural killer cell function in head and neck carcinoma 99
Is the natural history of hepatitis C virus carriers with normal aminotransferase really bening? 99
B lymphocyte activation in chronic HCV infection: implications for autoimmune and lymphoproliferative disorders 99
HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy 99
T-cell cytotoxicity and circulating T-cell subsets in chronic HBV infection 99
Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. 98
Defective cytotoxic function of intrahepatic natural killer cells in chronic hepatitis C virus infection 98
EASL Clinical Practice Guidelines: management of hepatitis C virus infection 98
The obesity paradox: Analysis from the SMAtteo COvid-19 REgistry (SMACORE) cohort 98
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 98
Viral and host immune regulatory mechanisms in HCV infection 97
HLA class II alleles confer protection or susceptibility to chronic hepatitis C 97
Epidemiology of HCV genotypes and risk of cirrhosis in apulia: a population-based case-control study 97
Characterization of cryoglobulins from patients with type II mixed cryoglobulinaemia associated with HCV 96
Optimization for the detection of hepatitis C virus (HCV) antigens in the liver 96
Detection of genomic and minus strand C virus RNA in the liver of chronic hepatitis C patients by strand-specific semi-quantitative RT-PCR 96
The impact of viral genotype on the natural history of HCV-induced cirrhosis: a prospective study 96
SIGNIFICANCE OF THE IMMUNE RESPONSE TO A MAJOR, CONFORMATIONAL B CELL EPITOPE ON THE HEPATITIS C VIRUS NS3 REGION DEFINED BY A HUMAN MONOCLONAL ANTIBODY 96
Genetic mechanisms of critical illness in COVID-19 96
Mutations at position 385 within the hypervariable region 1 (HVR1) of the hepatitis C virus (HCV) are rare and not rescricted to patients with cryoglobulinemia 95
Interferon-alpha enhances non-specific cytotoxicity for autologous hepatocytes in acute and chronic hepatitis B virus infection 95
Lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection. 95
A human monoclonal antibody against hepatitis B surface antigen with potent neutralizing activity 95
Hypervariable region 1 (HVR1) of HCV: immunological decoy or biologically relevant domain? 93
Assessment of HCV RNA clearance under combination therapy for HCV genotype 1: performance of the transcription-mediated amplification (TMA) assay. 93
Relationship between expression of HBV antigenes in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic HBV infection. 93
Direct-acting antivirals cure innate immunity in chronic hepatitis C 93
Hepatitis C virus (HCV) core serotypes in chronic HCV infection 93
Practice guidelines for the treatment of hepatitis C: Recommendations from an AISF/SIMIT/SIMAST expert opinion meeting 93
Totale 11.386
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.863
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.863
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.167 0 11 50 33 16 71 12 83 70 25 197 599
2022/20234.267 515 232 30 468 432 453 2 225 1.648 16 201 45
2023/20241.683 150 246 46 116 162 375 47 363 7 40 53 78
2024/20253.924 90 398 133 162 61 114 179 290 947 103 427 1.020
2025/20269.084 683 803 1.139 1.056 963 374 1.656 336 786 678 338 272
2026/2027640 222 418 0 0 0 0 0 0 0 0 0 0
Totale 28.160